Altus to buy MGC Diagnostics for about $50.3 mln

Altus Capital Partners has agreed to acquire St. Paul, Minnesota-based MGC Diagnostics Corp, a medical technology company, for $11.03 per share in cash or about $50.3 million. Craig-Hallum Capital Group LLC is providing financial advice to MGCD on the transaction.

27 November 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles